Life sciences firms' likelihood of locating manufacturing facilities in the U.S. 2018

This statistic depicts the percentage of medtech and biopharma firms that are likely to move existing manufacturing facilities or develop new manufacturing facilities in the U.S. due to the tax reform, according to a survey conducted during summer 2018. According to the survey, 48 percent of companies are likely to build new manufacturing facilities in the U.S. at that time.

Percentage of biopharma and medtech companies that are likely to have manufacturing facilities located in the U.S. due to tax reform as of 2018

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

October 2018

Region

Worldwide, United States

Survey time period

summer 2018

Number of respondents

60 executives

Special properties

30 from biopharma, 30 from medtech

Supplementary notes

Original question: "Has U.S. tax reform increased or decreased the likelihood your company will move existing manufacturing facilities back to the United States or locate a new manufacturing facilities in the United States?"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 / Month *
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Biogen"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.